Headline News about Amicus Therapeutics
![](https://investorplace.com/wp-content/uploads/2022/05/earnings-season-1600.png)
![](https://cdn.benzinga.com/files/images/story/2024/05/14/Image34.jpeg?width=1200&height=800&fit=crop)
![](https://investorplace.com/wp-content/uploads/2022/05/earnings-season-1600.png)
![](https://www.investors.com/wp-content/uploads/2017/05/IRU33.jpg)
![](https://www.investors.com/wp-content/uploads/2017/05/IRU33.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_1.png?width=1200&height=800&fit=crop)
The Analyst Landscape: 4 Takes On Amicus Therapeutics
December 19, 2023
Via Benzinga
![](/next-assets/images/schema-image-default.png)
Amicus Therapeutics: Q1 Earnings Insights
May 10, 2023
Via Benzinga
![](/next-assets/images/schema-image-default.png)
The Latest Analyst Ratings for Amicus Therapeutics
March 28, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/earnings_image_133.jpeg?width=1200&height=800&fit=crop)
![](https://investorplace.com/wp-content/uploads/2019/02/troublemsn.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/09/29/image29.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/09/28/fold.png?width=1200&height=800&fit=crop)
![](https://www.investors.com/wp-content/uploads/2017/05/IRU2.jpg)
![](https://www.investors.com/wp-content/uploads/2017/05/IRU5.jpg)
![](/next-assets/images/schema-image-default.png)
Earnings Preview: Amicus Therapeutics
February 28, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2022/10/31/aapharma_1.png?width=1200&height=800&fit=crop)
Via Benzinga
![](https://www.investors.com/wp-content/uploads/2017/05/IRU1.jpg)
![](https://www.investors.com/wp-content/uploads/2017/05/IRU4.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/05/10/aapharma_7.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/01/25/jim_cramer_scotte_beale.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/earnings_image_9795.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/11/01/biotech6.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/10/02/biotech13.jpg?width=1200&height=800&fit=crop)
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2022/08/31/biotech6.jpg?width=1200&height=800&fit=crop)
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2022/analyst_ratings_image_26295.jpeg?width=1200&height=800&fit=crop)
Benzinga's Top Ratings Upgrades, Downgrades For September 9, 2022
September 09, 2022
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2022/08/08/image-irobot.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/08/08/image47.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/08/03/image_7.jpg?width=1200&height=800&fit=crop)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.